Theia Pharmco Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.72 M
as on 22-12-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
About Theia Pharmco
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.72 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Theia Pharmco Private Limited India are Chandrashekharan Krishnamurthy as CEO and Ashwani Pushkarna as Ceo. Anup Tibrewal, Chandrashekharan Krishnamurthy, Ravi Singh, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33111DL2014PTC272987
- Company No.
272987
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Nov 2014
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Theia Pharmco?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chandrashekharan Krishnamurthy  | CEO | 10-Nov-2014 | Current |
| Ashwani Pushkarna | CEO | 01-Apr-2017 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anup Tibrewal | Additional Director | 14-Mar-2018 | Current |
| Chandrashekharan Krishnamurthy | Director and Ceo | 10-Nov-2014 | Current |
| Ravi Singh | Director | 20-Jan-2015 | Current |
| Ananya Basu | Director | 30-Jul-2015 | Current |
| Sunita Pushkarna | Director | 30-Jul-2015 | Current |
Financial Performance of Theia Pharmco.
Theia Pharmco Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Theia Pharmco?
In 2017, Theia Pharmco had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theia Pharmco?
Theia Pharmco has a workforce of 9 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theia Pharmco, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theia Pharmco's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
